Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19351632rdf:typepubmed:Citationlld:pubmed
pubmed-article:19351632lifeskim:mentionsumls-concept:C0004238lld:lifeskim
pubmed-article:19351632lifeskim:mentionsumls-concept:C2825055lld:lifeskim
pubmed-article:19351632lifeskim:mentionsumls-concept:C0547070lld:lifeskim
pubmed-article:19351632lifeskim:mentionsumls-concept:C0006560lld:lifeskim
pubmed-article:19351632lifeskim:mentionsumls-concept:C0205087lld:lifeskim
pubmed-article:19351632pubmed:issue5lld:pubmed
pubmed-article:19351632pubmed:dateCreated2009-4-29lld:pubmed
pubmed-article:19351632pubmed:abstractTextWe studied the C-reactive protein level and its predictive value for early and late arrhythmia recurrences after atrial fibrillation (AF) ablation. We analysed data from 125 consecutive patients (52% with paroxysmal AF) who underwent a first AF ablation. C-reactive protein level was determined at baseline and at Days 1, 2, and 3 post-AF ablation. An early recurrence (ER) was defined as any arrhythmia occurring within the first month following the index ablation. Sixty-eight patients (54%) experienced ER. Twenty-nine patients were re-ablated for ER within the first month and were not included for the long-term follow-up analysis. Of the remaining 96 patients, 59 (61%) experienced late recurrences. C-reactive protein level increased significantly after AF ablation with a peak (40 +/- 32 mg/L) occurring 2 days after the index procedure. Patients without ER had a significant higher C-reactive protein level (49 +/- 52 vs. 32 +/- 22 mg/L, P=0.02) compared with patients without ER. However, the C-reactive protein level was similar in patients with or without late recurrences. C-reactive protein level was the only independent predictor of ERs (P = 0.03). C-reactive protein level increased significantly after AF ablation. High C-reactive protein level was associated with fewer early arrhythmia recurrences. No relationship was found between C-reactive protein level and late arrhythmia recurrences.lld:pubmed
pubmed-article:19351632pubmed:languageenglld:pubmed
pubmed-article:19351632pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19351632pubmed:citationSubsetIMlld:pubmed
pubmed-article:19351632pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19351632pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19351632pubmed:statusMEDLINElld:pubmed
pubmed-article:19351632pubmed:monthMaylld:pubmed
pubmed-article:19351632pubmed:issn1532-2092lld:pubmed
pubmed-article:19351632pubmed:authorpubmed-author:JaïsPierrePlld:pubmed
pubmed-article:19351632pubmed:authorpubmed-author:HaïssaguerreM...lld:pubmed
pubmed-article:19351632pubmed:authorpubmed-author:WrightMatthew...lld:pubmed
pubmed-article:19351632pubmed:authorpubmed-author:LelloucheNico...lld:pubmed
pubmed-article:19351632pubmed:authorpubmed-author:SacherFrederi...lld:pubmed
pubmed-article:19351632pubmed:authorpubmed-author:MatsuoSeiichi...lld:pubmed
pubmed-article:19351632pubmed:authorpubmed-author:NaultIsabelle...lld:pubmed
pubmed-article:19351632pubmed:authorpubmed-author:KnechtSébasti...lld:pubmed
pubmed-article:19351632pubmed:authorpubmed-author:LomasOliverOlld:pubmed
pubmed-article:19351632pubmed:authorpubmed-author:BrottierJeanJlld:pubmed
pubmed-article:19351632pubmed:authorpubmed-author:HociniMéLèZeMlld:pubmed
pubmed-article:19351632pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19351632pubmed:volume11lld:pubmed
pubmed-article:19351632pubmed:ownerNLMlld:pubmed
pubmed-article:19351632pubmed:authorsCompleteYlld:pubmed
pubmed-article:19351632pubmed:pagination662-4lld:pubmed
pubmed-article:19351632pubmed:meshHeadingpubmed-meshheading:19351632...lld:pubmed
pubmed-article:19351632pubmed:meshHeadingpubmed-meshheading:19351632...lld:pubmed
pubmed-article:19351632pubmed:meshHeadingpubmed-meshheading:19351632...lld:pubmed
pubmed-article:19351632pubmed:meshHeadingpubmed-meshheading:19351632...lld:pubmed
pubmed-article:19351632pubmed:meshHeadingpubmed-meshheading:19351632...lld:pubmed
pubmed-article:19351632pubmed:meshHeadingpubmed-meshheading:19351632...lld:pubmed
pubmed-article:19351632pubmed:meshHeadingpubmed-meshheading:19351632...lld:pubmed
pubmed-article:19351632pubmed:meshHeadingpubmed-meshheading:19351632...lld:pubmed
pubmed-article:19351632pubmed:meshHeadingpubmed-meshheading:19351632...lld:pubmed
pubmed-article:19351632pubmed:meshHeadingpubmed-meshheading:19351632...lld:pubmed
pubmed-article:19351632pubmed:meshHeadingpubmed-meshheading:19351632...lld:pubmed
pubmed-article:19351632pubmed:meshHeadingpubmed-meshheading:19351632...lld:pubmed
pubmed-article:19351632pubmed:meshHeadingpubmed-meshheading:19351632...lld:pubmed
pubmed-article:19351632pubmed:meshHeadingpubmed-meshheading:19351632...lld:pubmed
pubmed-article:19351632pubmed:meshHeadingpubmed-meshheading:19351632...lld:pubmed
pubmed-article:19351632pubmed:meshHeadingpubmed-meshheading:19351632...lld:pubmed
pubmed-article:19351632pubmed:year2009lld:pubmed
pubmed-article:19351632pubmed:articleTitleUsefulness of C-reactive protein in predicting early and late recurrences after atrial fibrillation ablation.lld:pubmed
pubmed-article:19351632pubmed:affiliationHôpital Henri Mondor Fédération de Cardiologie, Assistance Publique Hôpitaux de Paris, Université de Médecine Paris XII, Créteil, France. nicolellouche@yahoo.comlld:pubmed
pubmed-article:19351632pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19351632pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:1401entrezgene:pubmedpubmed-article:19351632lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19351632lld:entrezgene